Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK
Conclusions
Despite an increase in high-intensity therapy use and a decline in revascularisation, more than half of patients did not receive high-intensity lipid-lowering therapy by 2017 and incidence rates of MI and IS remained virtually unchanged.
Source: BMJ Open - Category: General Medicine Authors: Danese, M., Sidelnikov, E., Villa, G., Catterick, D., Iqbal, M., Gleeson, M., Lubeck, D., Patel, J. Tags: Open access, Cardiovascular medicine Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | General Medicine | Heart | Heart Attack | Ischemic Stroke | Primary Care | Stroke | Study